Home
3.5.4 Kidney, bladder and ureter cancers
Foreword

Relevant news and research: Kidney, bladder and ureter cancers

Golomb, D., Atamna, F., Leonov Polak, M., Avda, Y. and Raz, O. (2025). Cumulative smoking exposure correlates with progression in high-grade T1 bladder cancer. Urologia, 3915603251390744. Available from: https://www.ncbi.nlm.nih.gov/pubmed/41181941


Calvet, F., Blanco Martinez-Illescas, R., Muinos, F., Tretiakova, M., Latorre-Esteves, E. S., Fredrickson, J., Andrianova, M., Pellegrini, S., Huber, A. R., Ramis-Zaldivar, J. E., An, S. C., Thieme, E., Kohrn, B. F., Grau, M. L., Gonzalez-Perez, A., Lopez-Bigas, N. and Risques, R. A. (2025). Sex and smoking bias in the selection of somatic mutations in human bladder. Nature. Available from: https://www.ncbi.nlm.nih.gov/pubmed/41062697


Martin, S. C. and Zhu, A. (2025). Editorial Comment on "Smoking is Associated with Poorer Survival Outcomes Following Nephroureterectomy for Upper Tract Urothelial Cancer". Urology. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40976270


Liu, Z. and Li, X. (2025). The Global Burden and Temporal Trend of Kidney, Bladder, and Prostate Cancers Attributed to Smoking From 1991 to 2021. Cureus, 6, e86389. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40688929


Park, J. H., Hong, J. Y., Han, K. and Shen, J. J. (2025). Sex-Specific Associations of Glycemic Status and Smoking with Bladder Cancer Risk: A Nationwide Cohort Study. Cancers (Basel), 13. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40647559


Wu, F., Wu, S., Huang, Y., Xiao, X., Yu, H., Bai, X., Zhang, C., Feng, Z., Li, L., Mei, Y., Li, X. and Gou, X. (2025). Smoking promotes the progression of bladder cancer through FOXM1/CKAP2L axis. J Transl Med, 1, 785. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40646610


Zhao, H., Liu, K., Crisci, A., Te Slaa, E., Habuchi, T., Akand, M., Ng, C. F., Laguna, P., Teoh, J. Y. and de la Rosette, J. (2025). Impact of smoking status at diagnosis on oncological outcomes of upper-tract urothelial carcinoma. Ther Adv Urol, 1.75629E+16. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40584958


Qi, D., Wang, B., Zhang, H., Xiong, F., Zhang, G. and Wang, C. (2025). Global burden of kidney cancer attributable to smoking: A systematic analysis of the 1990-2021 global burden of disease study. Prev Med Rep, 103096. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40469255


Wang, Y., Zhou, H., Tang, Z., He, Z., Zhuo, H., Huang, Y. and Kong, J. (2025). Smoking and bladder cancer: insights into pathogenesis and public health implications from a bibliometric analysis (1999-2023). Subst Abuse Treat Prev Policy, 1, 25. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40517257


Yu, Q., Li, B., Lin, H., Sun, C., Yang, X. and Zhang, Z. (2025). Smoking-related bladder cancer burden from 1990 to 2021: An age-period-cohort analysis of the global burden of disease study. Tob Induc Dis. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40510732


Chen, X., Hao, X., Wu, J. and Liu, X. (2025). The global burden of bladder, kidney, and prostate cancers attributable to smoking from 1990 to 2021 and projections for the next two decades: A cross-sectional study. Tob Induc Dis. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40417634


Zhu, H., Xiao, Q., Zhang, H., Zhou, M., Zhu, J., Zhang, S., Zhu, H., Zhang, Z. and Chu, H. (2025). Risk assessment for the bladder carcinogenesis of 4-aminobiphenyl in smokers: A source-to-outcome study. Toxicol Lett, 23-31. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40441369


de Andrade, D. P., Marques, C. M., de Andrade, D. C. R., Lenzi, L., Oliveira, C. S. and de Figueiredo, B. C. (2025). Trends in tobacco smoking and bladder and lung-bronchial cancer rates among non-hispanic white Americans (2000-2016). Arch Public Health, 1, 113. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40275317


Lin, C. H., Hung, P. H., Chang, C. H., Chang, H., Chung, M. C., Chang, W. C. and Chung, C. J. (2025). LINE-1 DNA methylation mediates smoking-related risk in site-specific urothelial carcinoma: a Taiwan case-control study. Arch Toxicol. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40285850


Aglago, E. K., Ramos, I., Keski-Rahkonen, P., Chatziioannou, C., Freisling, H., Fedirko, V., Gunter, M. J., Dahm, C. C., Langmann, F., Bondonno, N., Tjonneland, A., Severi, G., Truong, T., Katzke, V., Kaaks, R., Bergmann, M., Schulze, M. B., Masala, G., Pala, V., de Magistris, M. S., Di Girolamo, C., Lukic, M., Gram, I. T., Bonet, C., Sanchez, M. J., Chirlaque, M. D., Amiano, P., Guevara, M., Vermeulen, R., Manjer, J., Eriksson, L., Key, T. J., Mayen, A. L., Dossus, L., Weiderpass, E., Heath, A. K., Ferrari, P. and Jenab, M. (2025). Alcohol and smoking habits in association with hepatocellular carcinoma risk. Int J Cancer. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40098437


Deng, Y., Wang, Y., Yang, J., Luo, X., Qiu, J., Long, R., Zhang, C., Li, J., Tang, G., Chen, L. and Zuo, J. (2025). Global, Regional, and National Disease Burden and Prediction Analysis of Colorectal Cancer Attributable to Tobacco, Alcohol, and Obesity From 1990 to 2030. Front Oncol, 1524308. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40078186


Qi, K., Cheng, H., Jiang, Y. and Zheng, Y. (2025). Contribution of smoking to the global burden of bladder cancer from 1990 to 2021 and projections to 2046. Tob Induc Dis. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40161903


Zuo, J., Chen, J., Tan, Z., Zhu, X., Wang, H., Fu, S. and Wang, J. (2025). Analysis of long-term trends and 15-year predictions of smoking-related bladder cancer burden in china across different age and sex groups from 1990 to 2021. Discov Oncol, 1, 408. Available from: https://www.ncbi.nlm.nih.gov/pubmed/40146475


Bhanvadia, R., Bochner, E., Popokh, B., Taylor, J., Franco, A., Wu, Z., Antonelli, A., Ditonno, F., Abdollah, F., Simone, G., Tuderti, G., Correa, A., Ferro, M., Tozzi, M., Porpiglia, F., Tufano, A., Perdona, S., Broenimann, S., Singla, N., Derweesh, I. H., Gonzalgo, M. L., David, R. B., Mehrazin, R., Rais-Bahrami, S., Yong, C., Sundaram, C. P., Moghaddam, F. S., Ghoreifi, A., Djaladat, H., Autorino, R., Lotan, Y. and Margulis, V. (2025). Cumulative smoking exposure impacts oncologic outcomes of upper tract urothelial carcinoma. Urol Oncol. Available from: https://www.ncbi.nlm.nih.gov/pubmed/39956690


Akrami, R., Hadji, M., Rashidian, H., Nazemipour, M., Naghibzadeh-Tahami, A., Ansari-Moghaddam, A., Zendehdel, K. and Mansournia, M. A. (2025). Interaction between opium use and cigarette smoking on bladder cancer: An inverse probability weighting approach based on a multicenter case-control study in Iran. Glob Epidemiol, 100182. Available from: https://www.ncbi.nlm.nih.gov/pubmed/39846054


Han, S., Zhao, S., Zhong, R., Li, P., Pang, Y., He, S., Duan, J., Gong, H., Shi, J., Liu, L. and Yan, Y. (2024). Global burden, trends, and disparities in kidney cancer attributable to smoking from 1990 to 2021. Front Public Health, 1506542. Available from: https://www.ncbi.nlm.nih.gov/pubmed/39845663


Zhan, Y., Weng, M., Guo, Y., Lv, D., Zhao, F., Yan, Z., Jiang, J., Xiao, Y. and Yao, L. (2024). Identification and validation of the nicotine metabolism-related signature of bladder cancer by bioinformatics and machine learning. Front Immunol, 1465638. Available from: https://www.ncbi.nlm.nih.gov/pubmed/39742262


Contieri, R., Claps, F., Hurle, R., Buffi, N. M., Lughezzani, G., Lazzeri, M., Aveta, A., Pandolfo, S., Porpiglia, F., Fiori, C., Barone, B., Crocetto, F., Ditonno, P., Lucarelli, G., Lasorsa, F., Busetto, G. M., Falagario, U., Giudice, F. D., Maggi, M., Cantiello, F., Borghesi, M., Terrone, C., Bove, P., Antonelli, A., Veccia, A., Mari, A., Luzzago, S., Todea-Moga, C., Minervini, A., Musi, G., Fallara, G., Mistretta, F. A., Bianchi, R., Tozzi, M., Soria, F., Gontero, P., Marchioni, M., Janello, L. M. I., Terracciano, D., Russo, G. I., Schips, L., Perdona, S., Tataru, O. S., Vartolomei, M. D., Autorino, R., Catellani, M., Sighinolfi, C., Montanari, E., Stasi, S. M. D., Rocco, B., de Cobelli, O. and Ferro, M. (2024). Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy. Urol Oncol. Available from: https://www.ncbi.nlm.nih.gov/pubmed/39672689


 

Intro
Chapter 2